UnitedHealth Group Inc
UNH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$963.00 | Hnxlxsh | Cbzfgldgt |
UnitedHealth Earnings: Regulatory Concerns in Focus Despite Boost to 2023 Outlook
UnitedHealth turned in a strong start to the year, and management raised its guidance slightly for the full year on these strong trends. The new guidance range remains below our 2023 view, though, and we do not intend to change our $462 fair value estimate at first glance. Our economic moat rating also remains narrow and recognizes the long-term regulatory risks the company faces, primarily in medical insurance and pharmacy benefit management.